IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
The current price of IDXX is $572.69 USD — it has decreased by -1.78% in the past 24 hours. Watch Idexx Laboratories stock price performance more closely on the chart.
What is Idexx Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Idexx Laboratories stocks are traded under the ticker IDXX.
Is Idexx Laboratories stock price growing?▼
IDXX stock has fallen by -2.05% compared to the previous week, the month change is a -0.9% fall, over the last year Idexx Laboratories has showed a +40.68% increase.
What is Idexx Laboratories market cap?▼
Today Idexx Laboratories has the market capitalization of 45.6B
When is the next Idexx Laboratories earnings date?▼
Idexx Laboratories is going to release the next earnings report on May 05, 2026.
What were Idexx Laboratories earnings last quarter?▼
IDXX earnings for the last quarter are 3.08 USD per share, whereas the estimation was 2.93 USD resulting in a +5.01% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Idexx Laboratories revenue for the last year?▼
Idexx Laboratories revenue for the last year amounts to 8.61B USD.
What is Idexx Laboratories net income for the last year?▼
IDXX net income for the last year is 2.12B USD.
How many employees does Idexx Laboratories have?▼
As of April 21, 2026, the company has 11,000 employees.
In which sector is Idexx Laboratories located?▼
Idexx Laboratories operates in the Health & Wellness sector.
When did Idexx Laboratories complete a stock split?▼
The last stock split for Idexx Laboratories was on June 16, 2015 with a ratio of 2:1.
Where is Idexx Laboratories headquartered?▼
Idexx Laboratories is headquartered in Westbrook, United States.